Eli Lilly and Company
J Erik Fyrwald (Director) reports LLY insider transactions
AI-generated summary
Director J Erik Fyrwald received 7.9951 shares as a grant worth approximately $9,916.64 on October 19, 2026. Following this transaction, J Erik Fyrwald directly holds 75,544.1259 shares of common stock.
Key facts
- Insider
- J Erik Fyrwald · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 19, 2026 | A · grantFootnotes F1 | +7.9951 | $1,240.34 | $9,916.64 | 75,544.1259 | Direct |
Footnotes
- F1 At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.
More LLY filings
- 144
Filed Oct 30, 2026
- 10-Q
Filed Oct 29, 2026
- 8-K
Filed Oct 29, 2026
- 3
Filed Oct 22, 2026
- 4
Filed Oct 20, 2026
- 4
Filed Oct 20, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.